RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/53693
https://w3id.org/ripe/ripe-kg/retraction-notice/53693
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA01514B7E95B5311F |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA084C6EAC9724305F |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA0C83AF9CE6274D42 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA188DF79DAC4D30E2 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA1CF9367F3C1B1AFC |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA22B2228793442254 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA231DE1E46AB0E524 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA233158DEF9C3F087 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA3D5A3F568FA2F77D |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA3DB7B5186353EACB |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA4BED4D9BD987577D |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA4F5D57083F3F36E5 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA533765E11F40F1A0 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA534C4E03EC302AE0 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA55912887A066C004 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA56FDC28B3E9006DE |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA5D88C2D2406A5D02 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA624ED2A466C40B70 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA69C9C09037F4A7D7 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA6DC28A51A5E4686F |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA74BC134B1444B1E9 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA80149EADA6466949 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA83B5CB372F4B48C3 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA84BEB5719212517B |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA85E75680E0A580E5 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA8DB1A5C7D4B2BCF0 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA95D9EF8B2CE9BCA4 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA9FB7C0468A11295E |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAA8CC2475945829CC |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAC29393890CA84E8D |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAC60164BBD59BB4A3 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAE6C99CEB4A528D11 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAF3FB72DC47E629EA |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAF7E1928294A86E83 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEAFB2FF36932B98401 |
prov:used |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:doi |
10.1080/0167482x.2024.2346385 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:publicationDate |
2024-05-17 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:publicationName |
Journal of Psychosomatic Obstetrics & Gynecology |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:publisher |
ripekg:publisher/RIPEP08117F3F6484319BTaylor and Francis |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:title |
Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1080%2F0167482x.2017.1383381 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
owl:Thing |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
owl:sameAs |
https://semopenalex.org/work/W4397023263 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA01514B7E95B5311F |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA084C6EAC9724305F |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA188DF79DAC4D30E2 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA22B2228793442254 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA231DE1E46AB0E524 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA233158DEF9C3F087 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA3D5A3F568FA2F77D |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA533765E11F40F1A0 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA534C4E03EC302AE0 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA55912887A066C004 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA56FDC28B3E9006DE |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA5D88C2D2406A5D02 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA624ED2A466C40B70 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA6DC28A51A5E4686F |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA74BC134B1444B1E9 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA80149EADA6466949 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA83B5CB372F4B48C3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA84BEB5719212517B |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA85E75680E0A580E5 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA8DB1A5C7D4B2BCF0 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA95D9EF8B2CE9BCA4 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA9FB7C0468A11295E |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAA8CC2475945829CC |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC29393890CA84E8D |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE6C99CEB4A528D11 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF3FB72DC47E629EA |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF7E1928294A86E83 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAFB2FF36932B98401 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA01514B7E95B5311F |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA084C6EAC9724305F |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA188DF79DAC4D30E2 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA22B2228793442254 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA231DE1E46AB0E524 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA233158DEF9C3F087 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA3D5A3F568FA2F77D |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA533765E11F40F1A0 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA534C4E03EC302AE0 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA55912887A066C004 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA56FDC28B3E9006DE |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA5D88C2D2406A5D02 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA624ED2A466C40B70 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA6DC28A51A5E4686F |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA74BC134B1444B1E9 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA80149EADA6466949 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA83B5CB372F4B48C3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA84BEB5719212517B |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA85E75680E0A580E5 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA8DB1A5C7D4B2BCF0 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA95D9EF8B2CE9BCA4 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA9FB7C0468A11295E |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAA8CC2475945829CC |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC29393890CA84E8D |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE6C99CEB4A528D11 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF3FB72DC47E629EA |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF7E1928294A86E83 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAFB2FF36932B98401 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAU1712756B1250D256Fatemeh Foroozanfard |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAU29378092E98FE710Mehri Jamilian |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAU42780B0A182786C4Mehri Jamilian |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUAEB273847E760D0FFereshteh Bahmani |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUC4F4857955665209Hamidreza Jamilian |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUE7D584E6FC12675FMehri Jamilian |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:work/10.1080%2F0167482x.2017.1383381 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:rationale |
Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Investigation by Journal/Publisher;Investigation by Third Party;Objections by Author(s);Unreliable Results and/or Conclusions;Upgrade/Update of Prior Notice(s) |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:retractionWatchRecordId |
53693 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA01514B7E95B5311F-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA01514B7E95B5311F-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA084C6EAC9724305F-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA084C6EAC9724305F-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA188DF79DAC4D30E2-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA188DF79DAC4D30E2-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA231DE1E46AB0E524-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA231DE1E46AB0E524-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA233158DEF9C3F087-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA233158DEF9C3F087-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3D5A3F568FA2F77D-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3D5A3F568FA2F77D-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA533765E11F40F1A0-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA533765E11F40F1A0-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA55912887A066C004-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA55912887A066C004-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA56FDC28B3E9006DE-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA56FDC28B3E9006DE-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA5D88C2D2406A5D02-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA5D88C2D2406A5D02-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA624ED2A466C40B70-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA624ED2A466C40B70-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DC28A51A5E4686F-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DC28A51A5E4686F-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA74BC134B1444B1E9-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA80149EADA6466949-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA80149EADA6466949-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA83B5CB372F4B48C3-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA83B5CB372F4B48C3-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA84BEB5719212517B-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA84BEB5719212517B-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA85E75680E0A580E5-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA85E75680E0A580E5-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA8DB1A5C7D4B2BCF0-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA8DB1A5C7D4B2BCF0-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA95D9EF8B2CE9BCA4-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA95D9EF8B2CE9BCA4-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA9FB7C0468A11295E-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA9FB7C0468A11295E-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA8CC2475945829CC-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA8CC2475945829CC-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC29393890CA84E8D-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC29393890CA84E8D-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE6C99CEB4A528D11-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE6C99CEB4A528D11-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF3FB72DC47E629EA-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF3FB72DC47E629EA-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF7E1928294A86E83-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF7E1928294A86E83-inspectai-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAFB2FF36932B98401-human-1-3 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAFB2FF36932B98401-inspectai-1-3 |